337 related articles for article (PubMed ID: 16280002)
1. Are outcomes the same with all dry powder inhalers?
Thomas M; Williams AE
Int J Clin Pract Suppl; 2005 Dec; (149):33-5. PubMed ID: 16280002
[TBL] [Abstract][Full Text] [Related]
2. Can patients use all dry powder inhalers equally well?
Gustafsson P; Taylor A; Zanen P; Chrystyn H
Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
[TBL] [Abstract][Full Text] [Related]
3. Do healthcare professionals think that dry powder inhalers can be used interchangeably?
Price D
Int J Clin Pract Suppl; 2005 Dec; (149):26-9. PubMed ID: 16280000
[TBL] [Abstract][Full Text] [Related]
4. Could interchangeable use of dry powder inhalers affect patients?
Price D; Summers M; Zanen P
Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
[TBL] [Abstract][Full Text] [Related]
5. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
6. The way forward: dry powder inhalers should only be switched with physician agreement and patient training.
Price D
Int J Clin Pract Suppl; 2005 Dec; (149):36-7. PubMed ID: 16280003
[TBL] [Abstract][Full Text] [Related]
7. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
8. Do all dry powder inhalers show the same pharmaceutical performance?
Taylor A; Gustafsson P
Int J Clin Pract Suppl; 2005 Dec; (149):7-12. PubMed ID: 16279997
[TBL] [Abstract][Full Text] [Related]
9. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
Geller DE
Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
[TBL] [Abstract][Full Text] [Related]
10. Do patients think that dry powder inhalers can be used interchangeably?
Booker R
Int J Clin Pract Suppl; 2005 Dec; (149):30-2. PubMed ID: 16280001
[TBL] [Abstract][Full Text] [Related]
11. Use of a cognitive ergonomics approach to compare usability of a multidose dry powder inhaler and a capsule dry powder inhaler: an open-label, randomized, controlled study.
Franks M; Briggs P
Clin Ther; 2004 Nov; 26(11):1791-9. PubMed ID: 15639691
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized cross-over trial to assess the ability of a dry-powder inhaler to reverse the local side effects of pressurized metered-dose inhalers.
Bhalla RK; Watson G; Taylor W; Jones AS; Roland NJ
J Asthma; 2008 Nov; 45(9):814-9. PubMed ID: 18972301
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
[TBL] [Abstract][Full Text] [Related]
15. Stability and performance characteristics of a budesonide powder for inhalation with a novel dry powder inhaler device.
Fyrnys B; Stang N; Wolf-Heuss E
Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S7-11. PubMed ID: 11385814
[TBL] [Abstract][Full Text] [Related]
16. Problems with inhaler use: a call for improved clinician and patient education.
Fink JB; Rubin BK
Respir Care; 2005 Oct; 50(10):1360-74; discussion 1374-5. PubMed ID: 16185371
[TBL] [Abstract][Full Text] [Related]
17. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
Chan DS; Callahan CW; Hatch-Pigott VB; Lawless A; Proffitt HL; Manning NE; Schweikert MP
Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
[TBL] [Abstract][Full Text] [Related]
18. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
Henriet AC; Marchand-Adam S; Mankikian J; Diot P
Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
[TBL] [Abstract][Full Text] [Related]
19. Design, development and performance of a novel multidose dry-powder inhaler.
Parry-Billings M; Boyes RN; Clisby LM; Braithwaite P; Williams S; Harper AE
Med Device Technol; 1999 Nov; 10(9):24-8, 30, 32-4. PubMed ID: 10724653
[TBL] [Abstract][Full Text] [Related]
20. Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.
Donnell D
Eur Rev Med Pharmacol Sci; 2001; 5(1):7-16. PubMed ID: 11860222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
